Pharmacologic treatment of depression in patients with myocardial infarction

Depression is a common medical problem and is more prevalent among patients with coronary artery disease. Whether early detection and treatment of depression will enhance cardiovascular outcome is uncertain. Obviously, the safety and efficacy of the anti-depression drugs is an important link. This a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Jeong-Hoon, Wong, Cheuk-Kit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390082/
https://www.ncbi.nlm.nih.gov/pubmed/22783296
http://dx.doi.org/10.3724/SP.J.1263.2011.00121
_version_ 1782237396832616448
author Ha, Jeong-Hoon
Wong, Cheuk-Kit
author_facet Ha, Jeong-Hoon
Wong, Cheuk-Kit
author_sort Ha, Jeong-Hoon
collection PubMed
description Depression is a common medical problem and is more prevalent among patients with coronary artery disease. Whether early detection and treatment of depression will enhance cardiovascular outcome is uncertain. Obviously, the safety and efficacy of the anti-depression drugs is an important link. This article reviews the patho-physiologic and behavioural links between depression and cardiovascular disease progression, the treatment of depression, and the potential benefits of anti-depressants in patients with coronary disease.
format Online
Article
Text
id pubmed-3390082
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Science Press
record_format MEDLINE/PubMed
spelling pubmed-33900822012-07-10 Pharmacologic treatment of depression in patients with myocardial infarction Ha, Jeong-Hoon Wong, Cheuk-Kit J Geriatr Cardiol Review Depression is a common medical problem and is more prevalent among patients with coronary artery disease. Whether early detection and treatment of depression will enhance cardiovascular outcome is uncertain. Obviously, the safety and efficacy of the anti-depression drugs is an important link. This article reviews the patho-physiologic and behavioural links between depression and cardiovascular disease progression, the treatment of depression, and the potential benefits of anti-depressants in patients with coronary disease. Science Press 2011-06 /pmc/articles/PMC3390082/ /pubmed/22783296 http://dx.doi.org/10.3724/SP.J.1263.2011.00121 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Review
Ha, Jeong-Hoon
Wong, Cheuk-Kit
Pharmacologic treatment of depression in patients with myocardial infarction
title Pharmacologic treatment of depression in patients with myocardial infarction
title_full Pharmacologic treatment of depression in patients with myocardial infarction
title_fullStr Pharmacologic treatment of depression in patients with myocardial infarction
title_full_unstemmed Pharmacologic treatment of depression in patients with myocardial infarction
title_short Pharmacologic treatment of depression in patients with myocardial infarction
title_sort pharmacologic treatment of depression in patients with myocardial infarction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390082/
https://www.ncbi.nlm.nih.gov/pubmed/22783296
http://dx.doi.org/10.3724/SP.J.1263.2011.00121
work_keys_str_mv AT hajeonghoon pharmacologictreatmentofdepressioninpatientswithmyocardialinfarction
AT wongcheukkit pharmacologictreatmentofdepressioninpatientswithmyocardialinfarction

Ejemplares similares